Amber Siegel
Psychiatric/Mental Health · Orlando, FLNPI 1003371642
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 643 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Viiv Healthcare Company at 25.4% of the total. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 643 payments — averaging $26.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$4K
- Gilead$4K
- AbbVie$4K
- Theratechnologies Inc.$817
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$649
- Lilly USA, LLC$493
- plus $4K from 21 others
What the payments were for
- Consulting fees$4403%
- Speaking & faculty fees$390%
- Food & beverage$16,51197%
- Education$1141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 234 | $4,349 |
| Gilead | 103 | $3,646 |
| AbbVie | 125 | $3,627 |
| Theratechnologies Inc. | 34 | $817 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $649 |
| Lilly USA, LLC | 10 | $493 |
| Merck | 25 | $459 |
| Napo Pharmaceuticals Inc | 19 | $457 |
| Johnson & Johnson | 25 | $409 |
| Amgen | 3 | $406 |
| Vanda Pharmaceuticals Inc. | 13 | $354 |
| Antares Pharma, Inc. | 4 | $302 |
| EMD Serono, Inc. | 11 | $225 |
| Otsuka America Pharmaceutical, Inc. | 3 | $154 |
| Neurocrine Biosciences, Inc. | 2 | $137 |
| Paratek Pharmaceuticals, Inc. | 2 | $131 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Hologic Sales And Service, LLC | 1 | $67 |
| Abbott | 2 | $49 |
| Mayne Pharma Commercial LLC | 1 | $46 |
| Acerus Pharmaceuticals Corporation | 3 | $39 |
| AstraZeneca | 2 | $38 |
| Tolmar, Inc. | 2 | $34 |
| Novo Nordisk | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $32 |
| Vyera Pharmaceuticals, LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,104 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 56 | $225,413 |
| DovatoDolutegravir Sodium/Lamivudine | 39 | $102,098 |
| DescovyEmtricitabine/Tenofov Alafenam | 29 | $61,410 |
| MounjaroTirzepatide | 27 | $38,179 |
| DelstrigoDoravirine/Lamivu/Tenofov Diso | 14 | $35,268 |
| OzempicSemaglutide | 26 | $22,540 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $17,637 |
| Testosterone Cypionate | 32 | $1,586 |
| Proair RespiclickAlbuterol Sulfate | 14 | $995 |
| Rosuvastatin Calcium | 25 | $596 |
| Omega-3 Acid Ethyl Esters | 11 | $335 |
| Quetiapine Fumarate | 13 | $335 |
| Metoprolol Succinate | 32 | $215 |
| Atorvastatin Calcium | 35 | $123 |
| Bupropion XlBupropion Hcl | 19 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $3,646 | $286,82385 claims |
| Viiv Healthcare CompanyDovato | $4,349 | $102,09839 claims |
| Lilly USA, LLCMounjaro | $493 | $38,17927 claims |
| MerckDelstrigo | $459 | $35,26814 claims |
| Novo NordiskOzempic | $33 | $22,54026 claims |
| Teva Pharmaceuticals USA, Inc.Proair Respiclick | $13 | $99514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.